BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31020985)

  • 1. β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate.
    López Rivas P; Müller C; Breunig C; Hechler T; Pahl A; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
    Org Biomol Chem; 2019 May; 17(19):4705-4710. PubMed ID: 31020985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.
    Raposo Moreira Dias A; Pina A; Dean A; Lerchen HG; Caruso M; Gasparri F; Fraietta I; Troiani S; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
    Chemistry; 2019 Feb; 25(7):1696-1700. PubMed ID: 30452790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
    E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression.
    Shan X; Zhang L; Xu Y; Sun L; Guo L; Feng S; Ge H; Gu T; Ning X
    Chem Commun (Camb); 2020 Feb; 56(14):2178-2181. PubMed ID: 31971174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic simplified tubulysin analogues.
    Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
    J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
    Dayam R; Aiello F; Deng J; Wu Y; Garofalo A; Chen X; Neamati N
    J Med Chem; 2006 Jul; 49(15):4526-34. PubMed ID: 16854058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Targeting with an isoDGR-Drug Conjugate.
    Zanella S; Angerani S; Pina A; López Rivas P; Giannini C; Panzeri S; Arosio D; Caruso M; Gasparri F; Fraietta I; Albanese C; Marsiglio A; Pignataro L; Belvisi L; Piarulli U; Gennari C
    Chemistry; 2017 Jun; 23(33):7910-7914. PubMed ID: 28449309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugates of a novel 7-substituted camptothecin with RGD-peptides as α(v)β₃ integrin ligands: An approach to tumor-targeted therapy.
    Dal Pozzo A; Esposito E; Ni M; Muzi L; Pisano C; Bucci F; Vesci L; Castorina M; Penco S
    Bioconjug Chem; 2010 Nov; 21(11):1956-67. PubMed ID: 20949910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
    Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
    ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy.
    Legigan T; Clarhaut J; Renoux B; Tranoy-Opalinski I; Monvoisin A; Jayle C; Alsarraf J; Thomas M; Papot S
    Eur J Med Chem; 2013 Sep; 67():75-80. PubMed ID: 23845743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of the putative structure of lucentamycin A.
    Pal U; Ranatunga S; Ariyarathna Y; Del Valle JR
    Org Lett; 2009 Nov; 11(22):5298-301. PubMed ID: 19863114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands.
    Urman S; Gaus K; Yang Y; Strijowski U; Sewald N; De Pol S; Reiser O
    Angew Chem Int Ed Engl; 2007; 46(21):3976-8. PubMed ID: 17394270
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-Cytotoxicity Relationships of Analogues of N
    Toader D; Wang F; Gingipalli L; Vasbinder M; Roth M; Mao S; Block M; Harper J; Thota S; Su M; Ma J; Bedian V; Kamal A
    J Med Chem; 2016 Dec; 59(23):10781-10787. PubMed ID: 27809515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
    Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
    Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.
    Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U
    Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
    Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
    Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.